Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Sep 24, 2009 11:02am
56 Views
Post# 16334899

More numbers to annoy Pepcrap

More numbers to annoy PepcrapIn PI 6 out 7 patient that got more than 6 cycle got SD (stable disease).

In analyst conference day, Thallion said that they were aiming for 20% ore more SD or TR to call PII a success.
From PI data, the success rate is 86%.

We need 20% to pass and clear FDA approval.

A nice buffer of 66%.

1st cohort of patient is between 18 to 20 patients.

Again, Pepcrap, congrats on Methylcrap news. I guess you are "trap" in the lobster cage... YUP YUP YUP YUP...
<< Previous
Bullboard Posts
Next >>